» Articles » PMID: 39116057

Smooth Muscle Electromyography for Detecting Major Alterations in the Estrus Cycle in Rats

Overview
Journal PLoS One
Date 2024 Aug 8
PMID 39116057
Authors
Affiliations
Soon will be listed here.
Abstract

Determining the female animal cycle is crucial in preclinical studies and animal husbandry. Changes in hormone levels during the cycle affect physiological responses, including altered contractility of the visceral smooth muscle. The study aimed to identify estrus and anestrus using smooth muscle electromyographic (SMEMG) measurements, in vivo fluorescent imaging (IVIS) and in vitro organ contractility of the uterus and cecum. The study involved sexually mature female Sprague-Dawley rats, aged 10-12 weeks. The rats received a daily injection of cetrorelix acetate solution for 7 days, while another group served as the control. The animals were subjected to gastrointestinal and myometrial SMEMG. The change in αvβ3 integrin activity was measured with IVIS in the abdominal cavity. Contractility studies were performed in isolated organ baths using dissected uterus and cecum samples. Plasma samples were collected for hormone level measurements. A 3-fold increase in spontaneous contraction activity was detected in SMEMG measurements, while a significant decrease in αvβ3 integrin was measured in the IVIS imaging procedure. Cetrorelix reduced the level of LH and the progesterone / estradiol ratio, increased the spontaneous activity of the cecum rings, and enhanced KCl-evoked contractions in the uterus. We found a significant change in the rate of SMEMG signals, indicating simultaneous increases in the contraction of the cecum and the non-pregnant uterus, as evidenced by isolated organ bath results. Fluorescence imaging showed high levels of uterine αvβ3 integrin during the proestrus-estrus phase, but inhibiting the sexual cycle reduced fluorescence activity. Based on the results, the SMEMG and IVIS imaging methods are suitable for detecting estrus phase alterations in rats.

Citing Articles

The Mechanism Involved in the Inhibition of Resveratrol and Genistein on the Contractility of Isolated Rat Uterus Smooth Muscle.

Ma Q, Wang Y, Zhang W, Du Z, Tian Z, Li H Nutrients. 2024; 16(19).

PMID: 39408382 PMC: 11478625. DOI: 10.3390/nu16193417.

References
1.
Gharibans A, Hayes T, Carson D, Calder S, Varghese C, Du P . A novel scalable electrode array and system for non-invasively assessing gastric function using flexible electronics. Neurogastroenterol Motil. 2022; 35(2):e14418. PMC: 10078595. DOI: 10.1111/nmo.14418. View

2.
Horvath J, Toller G, Schally A, Bajo A, Groot K . Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats. Proc Natl Acad Sci U S A. 2004; 101(14):4996-5001. PMC: 387362. DOI: 10.1073/pnas.0400605101. View

3.
Tur-Kaspa I, Ezcurra D . GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology. Expert Opin Drug Metab Toxicol. 2009; 5(10):1323-36. DOI: 10.1517/17425250903279969. View

4.
Gaddum J . The technique of superfusion. 1953. Br J Pharmacol. 1997; 120(4 Suppl):82-7; discussion 80-1. PMC: 3224274. DOI: 10.1111/j.1476-5381.1997.tb06779.x. View

5.
Goldman J, Murr A, Cooper R . The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol. 2007; 80(2):84-97. DOI: 10.1002/bdrb.20106. View